Coherus BioSciences Inc Stock Price. Everything You Need To Know About The Coherus BioSciences Inc Stock! Coherus BioSciences Inc Stock Price. Everything You Need To Know About The Coherus BioSciences Inc Stock!


Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. The company is headquartered in Redwood City, California and currently employs 359 full-time employees. The company went IPO on 2014-11-06. The firm is focused on the research, development, and commercialization of immunotherapies to treat cancer. The company operates in the business of developing and commercializing the human pharmaceutical products segment. The Company’s product pipeline comprises three product candidates, toripalimab, an anti-PD-1 antibody being developed in collaboration with Junshi Biosciences; CHS-006, an antibody targeting TIGIT being developed in collaboration with Junshi Biosciences; and one wholly owned preclinical immuno-oncology program, CHS-1000, an antibody targeting ILT4. The firm markets UDENYCA (pegfilgrastim-cbqv), a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor, in the United States (the U.S). The company also sells CIMERLI (ranibizumab-eqrn), a biosimilar of Lucentis, in the U.S. The firm also focused on developing Humira, a biosimilar YUSIMRY (adalimumab-aqvh) in the U.S.



Coherus BioSciences Inc Stock Price. Everything You Need To Know About The Coherus BioSciences Inc Stock! performance

  • Employees 359
  • Company HQ Redwood City
  • Website https://www.coherus.com/
  • CHRS Asset Type Common Stock
  • CHRS Market Capitalization 190.4M
  • Earnings Per Share -0.74
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth -0.755

Coherus BioSciences, a renowned biotechnology company, presents an attractive investment opportunity for retail investors in Malaysia, Thailand, Indonesia, and Vietnam. With Zorion’s user-friendly investment platform, investing in Coherus BioSciences becomes effortless. Coherus BioSciences focuses on creating cost-effective biosimilar therapeutics that provide affordable treatment options for patients. Through extensive research and development, Coherus BioSciences has successfully developed multiple biosimilar drugs that target various diseases. Retail investors can rely on Zorion’s investment insights and recommendations to navigate the market and make informed decisions. Additionally, Zorion provides access to educational materials and resources to enhance investors’ knowledge and understanding of Coherus BioSciences and the biotechnology industry. Invest smartly with Zorion and capitalize on the potential growth of Coherus BioSciences.


Want To Buy Coherus BioSciences Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: